SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-087737
Filing Date
2016-11-23
Accepted
2016-11-23 13:35:03
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 8715
  Complete submission text file 0001140361-16-087737.txt   10440
Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ
Business Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ 44 0 1980 753002
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARBYLAN THERAPEUTICS, INC. 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address
Renzi David (Reporting) CIK: 0001631294 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 162015923